{
    "SPADE_UN_21641": {
        "Sequence Information": {
            "Peptide Name": "HB43, FLAK50 AMD",
            "Sequence": "FAKLLAKLAKKLL",
            "Sequence Length": 13,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Antifungal",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Antimicrobial peptide therapeutics for cystic fibrosis.",
                    "Pubmed ID": "15980369",
                    "Reference": "Antimicrob Agents Chemother. 2005;49:2921-2927",
                    "Author": "Zhang L, Parente J, Harris SM, Woods DE, Hancock RE, Falla TJ",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/15980369"
                },
                {
                    "Title": "Designing Anticancer Peptides by Constructive Machine Learning.",
                    "Pubmed ID": "29679519",
                    "Reference": "ChemMedChem. 2018;13:1300-1302",
                    "Author": "Grisoni F, Neuhaus CS, Gabernet G, Müller AT, Hiss JA, Schneider G",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29679519"
                },
                {
                    "Title": "Short bioactive peptides",
                    "Pubmed ID": "",
                    "Reference": "PATENT US 6875744B2. 2005;:",
                    "Author": "Owen DR, Kenner LA",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"
                }
            ],
            "Mass": 1456.9,
            "PI": 10.48,
            "Net Charge": 4,
            "Hydrophobicity": 0.89,
            "Frequent Amino Acids": "LKA",
            "Absent Amino Acids": "CDEGHIMNOPQRSTUVWY",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 4,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_21641",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_06645",
                    "Similarity": 1.0,
                    "Sequence": "FAKKLAKKLL"
                },
                {
                    "SPADE_ID": "SPADE_N_06671",
                    "Similarity": 1.0,
                    "Sequence": "FAKLLAKKLL"
                },
                {
                    "SPADE_ID": "SPADE_N_06672",
                    "Similarity": 1.0,
                    "Sequence": "FAKLLAKLAK"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=13.2 µM,Human fibroblasts WI-38:LD50=5 µg/ml,Human leukocytes:LD50=70 µg/ml",
            "Target Organism": "Escherichia coli UB1005(MIC=4µg/ml),Salmonella enterica serovar Typhimurium(MIC=4µg/ml),Pseudomonas aeruginosa(MIC=8µg/ml),Pseudomonas aeruginosa M76(MIC=4µg/ml),Pseudomonas aeruginosa M917(MIC=16µg/ml),Pseudomonas aeruginosa M1251(MIC=4µg/ml),Pseudomonas aeruginosa M1426(MIC=8µg/ml),Pseudomonas aeruginosa R70(MIC=4µg/ml),Staphylococcus aureus(MIC=4µg/ml),Candida albicans(MIC=8µg/ml),Pseudomonas stutzeri(MIC=4µg/ml),Pseudomonas fluorescens(MIC=8µg/ml),Stenotrophomonas maltophilia(MIC=2µg/ml),Achromobacter xylosoxidans(MIC=64µg/ml),Human breast adenocarcinoma MCF-7(EC50=6µM),Staphylococcus aureus ATCC 6538(MIC=5µg/ml),Pseudomonas aeruginosa ATCC 9027(MIC=100µg/ml),Saccharomyces cerevisiae(MFC=25µg/ml),Escherichia coli ATCC 25922(MBC=8µg/ml),Pseudomonas aeruginosa ATCC 27853(MBC=15µg/ml),Staphylococcus aureus ATCC 25923(MBC=4µg/ml),Candida albicans ATCC 10231(MFC=15µg/ml),Human colon adenocarcinoma SW480(LD50=9µg/ml),Human melanoma BMKC(LD50=7µg/ml),Human lung carcinoma H1299(LD50=6µg/ml),Human cervical carcinoma HeLa S3(LD50=15µg/ml),Human prostate adenocarcinoma PC-3(LD50=12µg/ml)"
        }
    }
}